These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 14748489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Sidwell RU, Swift S, Yan CL, Porter W, Thompson EM, Clark JA, Bunker CB.
    Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
    Trent J, Halem M, French LE, Kerdel F.
    Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR.
    Pediatr Dermatol; 2005 Jun; 22(4):317-20. PubMed ID: 16060867
    [Abstract] [Full Text] [Related]

  • 7. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE, Trent JT, Kerdel FA.
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Toxic epidermal necrolysis successfully treated with etanercept.
    Gubinelli E, Canzona F, Tonanzi T, Raskovic D, Didona B.
    J Dermatol; 2009 Mar; 36(3):150-3. PubMed ID: 19335689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravenous immunoglobulin for the treatment of toxic epidermal necrolysis.
    Trent JT, Kerdel FA.
    Arch Dermatol; 2003 Aug; 139(8):1081. PubMed ID: 12925403
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin in toxic epidermal necrolysis.
    Pasic S.
    Int J Dermatol; 2006 Sep; 45(9):1117-8. PubMed ID: 16961531
    [No Abstract] [Full Text] [Related]

  • 15. Acetaminophen-induced toxic epidermal necrolysis in a child.
    Bygum A, Gregersen JW, Buus SK.
    Pediatr Dermatol; 2004 Sep; 21(3):236-8. PubMed ID: 15165202
    [Abstract] [Full Text] [Related]

  • 16. Severe cutaneous adverse reactions to drugs.
    Chia FL, Leong KP.
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [Abstract] [Full Text] [Related]

  • 17. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P, Kaveri S, Jacob E, Pirson J, Quatresooz P, Piérard GE.
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [Abstract] [Full Text] [Related]

  • 18. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M.
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N, Arun J, Osama NE, Amr Z, Mazen AS, Ibtesam el-A, Nazeha el-B.
    Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.